Press Release

CREATIVE DIAGNOSTICS ANNOUNCES MDT SERVICES FOR MEASURING ANTIBACTERIAL EFFECTIVENESS



Creative Diagnostics Announces MDT Services for Measuring Antibacterial Effectiveness

FOR IMMEDIATE RELEASE

23/01/2024

As an expert in providing solutions to assist virology and microbiology research, Creative Diagnostics has announced the availability of its new Minimum Doubling Time (MDT) services to rapidly and accurately measure the effectiveness of antibacterial compounds. The new services offer a simple and efficient way to determine how quickly bacteria grow in the presence of antibiotics, providing valuable insights for researchers in the field of antimicrobial drug discovery.

Under favorable conditions, microorganisms continuously absorb nutrients and perform metabolic activities according to their own metabolic laws. When assimilation is greater than dissimilation, the number and volume of microbial cytoplasm increase, so the microorganisms are in a state of growth.

The growth of unicellular microorganisms such as bacteria is often accompanied by an increase in the number of cells. When the cell grows to a certain extent, it will form two essentially identical daughter cells in the form of dikaryosis, and the daughter cells will repeat the above process. In unicellular microorganisms, the increase in the number of individuals caused by cell division is called reproduction. In general, growth and reproduction always alternate under suitable environmental conditions. From growth to reproduction is a process of qualitative change to quantitative change, and this process is development.

If the physical and chemical conditions are suitable, microorganisms can grow and develop normally, and the reproduction rate is also high; if a certain or some environmental conditions change beyond the scope of biological adaptability, it will inhibit or even kill the microorganisms. Therefore, by measuring the growth curves of microorganisms, researchers can understand the growth pattern of various bacteria and microorganisms, which is of great significance for scientific research.

The MDT test is used to determine the time it takes for the number of bacteria to double. This experiment illustrates the effect of antibiotics on bacterial growth by comparing the effect of adding and not adding antimicrobial compounds on bacterial growth in broth culture.

There are several methods for determining microbial enumeration that can be selected according to requirements and laboratory conditions. Since the concentration of a bacterial suspension is directly proportional to the optical density (OD), Creative Diagnostics generally uses a spectrophotometer to evaluate the OD of a bacterial suspension to infer the concentration of the bacterial suspension, plot a growth curve, and calculate the minimum doubling time.

Creative Diagnostics combines infectious disease and analytical expertise to provide customers with the most robust portfolio of antiviral and antibacterial in vitro testing services. The MDT services allows scientists to accurately assess how quickly bacteria double in size in response to different antibiotic treatments, offering valuable insights into the effectiveness of antibiotics and potentially accelerating the development of new drugs.

Creative Diagnostics offers MDT services to help researchers quickly determine the effect of antibiotics on bacterial growth. For more information, please visit https://antiviral.creative-diagnostics.com/minimum-doubling-time-growth-curve-mdt.html.

About Creative Diagnostics

Headquartered in New York, Creative Diagnostics is a consulting and experimental service provider specializing in virology and microbiology. The company provides comprehensive solutions to conquer obstacles in virology and microbiology research, from high-security infrastructure provision, biosafety regulation elucidation, to expert viral system assistance.

Tags:
MDT Services  |  Creative Diagnostics  |  

---

Organisation Profile:
Creative Diagnostics is a leading manufacturer and supplier of antibodies, viral antigens, innovative diagnostic components, and critical assay reagents. We provide contract biologic R&D and manufacturing services to the diagnostic manufacturers along with GMP biologics manufacturing for the biopharmaceutical market. Our goal is to be a trusted source for all your assay development and manufacturing needs.






Press release contact details for Creative Diagnostics

NameCreative Diagnostics
Tel
Fax
Email
Websitehttps://www.creative-diagnostics.com/
OrganisationCreative Diagnostics
Address
Town
County0
Postcode11967




Other press releases from Creative Diagnostics

Creative Diagnostics Launches HPV L1 Antibodies for Neutralization and Vaccine Development
Creative Diagnostics Introduces TCID50 Assay Service for Determining Viral Titers
Creative Diagnostics Introduces ELISA Kit Development Services to Support IVD Research
Creative Diagnostics Introduces Microneutralization Assay Service for Virus Detection
Creative Diagnostics Introduces Virus Yield Reduction Assay Service
Creative Diagnostics Introduces New Low Endotoxin Antibodies for Researchers
Creative Diagnostics Announces Calprotectin Reagents for Inflammatory Disease Research
Creative Diagnostics Introduces Viral Replicon Assay Service to Support Virology Research
Creative Diagnostics Announces the Launch of Radial Immunodiffusion Testing Service
Creative Diagnostics Launches Highly Specific Antibodies Against FXIIIa/F13A1 for Vascular Diseases
Creative Diagnostics Introduces qPCR Assay for Rapid Virus Detection and Quantification
Creative Diagnostics Launches New Reagent Solutions for Herpesvirus Research
Creative Diagnostics Announces New Reagents for Bioanalysis of Antibody Drug Conjugates
Creative Diagnostics Announces New Antimicrobial Susceptibility Testing Services
Creative Diagnostics Introduces New ELISA Kits to Accelerate Autoimmunity Research
Creative Diagnostics Launches Antimicrobial Synergy Testing Services
Creative Diagnostics Launches New Azaperone Test Reagents for Research Applications
Creative Diagnostics Launches Checkerboard Assay Services
Creative Diagnostics Launches New Anti-Small Molecule Label Antibodies to Facilitate NALFIA Development
Creative Diagnostics Announces New CLDN6 Solutions for Cancer Research
Creative Diagnostics Launches Minimum Inhibitory Concentration Testing Services
Creative Diagnostics Launches Carbamazepine Test Reagents
Creative Diagnostics Launches Macrophage Migration Inhibitory Factor Reagents for Research Applications
Creative Diagnostics Announces New Test Reagents for Dapsone
Creative Diagnostics Announces New MBC Assay for Antibacterial Testing Read more: https://www.digitaljournal.com/pr/news/getnews/creative-diagnostics-announces-new-mbc-assay-for-antibacterial-testing#ixzz8KcL65cji
Creative Diagnostics Announces New MBC Assay for Antibacterial Testing
Creative Diagnostics Launches Rapid Robenidine Test Reagents for the Analysis of Anticoccidial Residues
Creative Diagnostics Announces MDT Services for Measuring Antibacterial Effectiveness
Creative Diagnostics Launches New P53 and TP53 Antibodies for Cancer Research
Creative Diagnostics Launches Aflatoxin Test Reagents to Ensure Food Safety
Creative Diagnostics Launches Serum Plate Agglutination Test for In Vitro Detection of Multiple Pathogens
Creative Diagnostics Announces New AAV Reagent Solutions for Gene Therapy
Citrinin Test Reagents for Food Safety
Creative Diagnostics Announces Novel Agar Gel Precipitin Tests for Viral Antigen Detection
Creative Diagnostics Introduces Cutting-Edge Anti-AAV Antibody ELISA Kits for Gene Therapy Research
Creative Diagnostics Announces the Launch of Its Highly Sensitive Kanamycin ELISA Kit for Precise Antibiotic Detection
Creative Diagnostics Launches Comprehensive ELISA Based Assays for Vaccine Development
Creative Diagnostics Announces Comprehensive Vomitoxin Test Reagents for Food Safety Applications
High-Affinity Anti Venom Antibodies for Research Applications
Creative Diagnostics Introduces Immunofluorescence Assay Testing Services for Virology Research
Creative Diagnostics Launches Comprehensive Fumonisin Test Reagents for Precise Food Safety Analysis
Creative Diagnostics Introduces Comprehensive Range of Ochratoxin Test Reagents for Enhanced Food Safety Analysis
Creative Diagnostics Launches Plaque Reduction Assay Services to Advance Antiviral Research
Creative Diagnostics Announces the Launch of Norovirus VLP Antigens to Support Vaccine Research
Creative Diagnostics Introduces Patulin Test Reagents for Food Safety Applications
Creative Diagnostics Launches Reliable Hemagglutination Assay for Virus and Antibody Detection
Creative Diagnostics Announces High-Affinity Anti-Adenovirus Monoclonal Antibodies for Research and Assay Development
Animal-Derived DNA Residue Assay Kits (qPCR) for Research Applications
Creative Diagnostics Introduces Alternariol Test Reagents for Food Safety Detection
Creative Diagnostics Announces New Coronavirus Animal Model for Drug Discovery
Creative Diagnostics Introduces New Anti-RBC Antibodies for Enhanced Blood Product Purity and Autoimmune Disease Research

Disclaimer:
Issuers of the press releases are solely responsible for the content of their press releases. Connect2business.co.uk cannot be held liable for the content posted by others to this website.